Revolymer PLC (LSE:REVO) - Overview

Stock Report

Revolymer PLC REVO

Last Price
GBX28.50

Day Change
-2.00|-6.56%

As of 07/12/2016
15:19:38 GMT | GBX
Minimum 15 Minutes Delay.

Last Close30.50p
Day Range28.00 - 30.05
Mkt Cap22.42Mil
52-Wk Range27.00 - 74.25
Yield %0.00
ISINGB00B84LVH87
Volume18,577
P/E-8.91
P/S12.91
P/CF-6.47

Share Price

Total Returns 09/12/2016

 Chg (%)  
More ...
Revolymer PLC-12.31 
FTSE 100 TR GBP1.05
 
Financials
201320142015
More ...
Income Statement
Turnover0.531.021.25
Operating Profit-5.48-4.41-3.67
Net Profit-5.28-4.30-1.79
Reported EPS-9.80-7.70-3.20
Balance Sheet
Current Assets18.3813.8911.70
Non Current Assets0.360.310.34
Total Assets18.7514.2012.04
Current Liabilities2.311.821.71
Total Liabilities2.661.821.71
Total Equity16.0812.3910.32
Cash Flow
Operating Cash Flow-4.31-4.70-2.60
Net Change in Cash-2.72-0.501.83
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-4.60-6.06--4.70---
2017-4.14-4.75--6.00---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
13/10/2016PurchaseJack Keenan34.00150,00051,000.00
13/10/2016PurchaseMr. Mike Townend34.0029,0009,860.00
13/10/2016PurchaseDr. Bryan Dobson34.0014,5004,930.00
05/10/2016PurchaseDr. Jim Barber32.0045,00014,400.00

Company Profile

Revolymer PLC designs, develops and formulates novel polymers to improve the performance of its customers' and partners' products. The markets served are Household Products, Personal Care and Nicotine Gum.
 

Sector

Specialty Chemicals

Market Position

1301 of 1863 Companies

Index

FTSE AIM All Share

Outlook

(22/09/2016) "...to deliver revenues and progress towards sustainable profitability in the medium term"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-5.9016.5916.09
Div Yld (E)0.002.604.23
PEG (E)0.002.100.59
ROCE-34.7324.8379.03
Op Mrgn-294.089.10-13.33
EPS Grwth0.0010.6122.92
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Bryan Dobson
Chief Executive OfficerDr. Kevin Matthews
Chief Financial Officer & Company SecretRob Cridland
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.